Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-09-26 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
关于重新签订募集资金专户三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the re-signing of a tripartite supervision agreement for the use of raised funds by Shanghai Chenguang Medical Technology Co., Ltd. It details the background of the fundraising, changes in the use of funds, the signing of the new supervision agreement, and the specifics of the agreement. There are no financial statements or comprehensive financial data presented. The document is primarily an update on capital management and regulatory compliance related to fundraising activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters but contains substantive content about fundraising and capital use, not just a report publication announcement or a brief notice.
2024-09-26 Chinese
高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel, specifically the Vice General Manager and R&D Director. It details the resignation date, reasons, and the impact on the company's board and operations. There is no financial data, report, or presentation included. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2024-09-26 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is an investor relations activity record from Shanghai Chiguang Medical Technology Co., Ltd., specifically an earnings explanation meeting held on September 13, 2024. It contains detailed Q&A responses about the company's financial performance, business operations, strategic plans, and market conditions. The content is typical of a call or meeting transcript where management addresses investor questions about recent financial results and company outlook. The document length is 3926 characters, which is relatively short but contains substantive discussion rather than just an announcement or summary. It is not a formal earnings release (ER) which usually contains key financial highlights only, nor is it a full annual or interim report. The detailed Q&A format and focus on performance explanation aligns best with a Call Transcript (CT).
2024-09-18 Chinese
2024年第二次临时股东大会决议
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 second extraordinary general meeting of shareholders of Shanghai Chenguang Medical Technology Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and votes. The content focuses on the voting outcomes and procedural details of the shareholders' meeting rather than presenting financial data, management discussion, or other report types. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is under 5,000 characters and contains full voting results, not just a brief announcement or a link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is DVA with high confidence.
2024-09-18 Chinese
关于辰光医疗2024年第二次临时股东大会之法律意见书
Regulatory Filings
2024-09-18 Chinese
关于参加2024年上海辖区上市公司投资者网上集体接待日暨中报业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement from Shanghai Chenguang Medical Technology Co., Ltd. about their participation in a 2024 mid-year performance explanation meeting (业绩说明会) related to their 2024 half-year report. It references the previously disclosed 2024 half-year report (公告编号：2024-070) and a summary (公告编号：2024-071), but this document itself does not contain financial statements or substantive financial data. Instead, it announces the date, time, and participation details for an investor presentation event discussing the half-year results. The document length is short (1073 characters) and serves as a notice for an upcoming event rather than the report itself. Therefore, it fits best under Investor Presentation (IP) category, as it focuses on a detailed presentation for investors about financials, strategy, and market position related to the half-year report.
2024-09-08 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.